March 2022 saw gallbladder disease added to labels, September 2023 brought ileus warnings, and November 2024 added pulmonary aspiration risks each update coming only after patients suffered these exact injuries
2025 Impact of transfusion dependent alpha- and beta-thalassemia on adult patients health-related quality of life and work productivity: A multi-region real-world survey Janet Kwiatkowski 1 , Khaled Musallam 2 , Maria Domenica Cappellini 3 , Christina Chamberlain 4 , Amey Rane 4 , Keely Gilroy 4 , Susan Morris 4 , Emma Chatterton 5 , Brianne Kerr 5 , Katie Lewis 5 , Ali Taher 6 1 Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, USA, 2 Burjeel Medical City, Abu Dhabi, United Arab Emirates, 3 Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy, 4 Agios Pharmaceuticals, Cambridge, Massachusetts, USA, 5 Adelphi Real World, Bollington, UK, 6 American University of Beirut Medical Centre, Beirut, Lebanon Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2025 Aims Research on the impact of transfusion-dependent thalassemia (TDT) on health-related quality of life (HRQoL) and work productivity is limited, particularly in -TDT
Compounding pharmacies that conduct rigorous stability testing may assign BUDs of up to 120 days
However, this doesnt happen with type 2 diabetes, which is how Mounjaro and Ozempic can help since they artificially mimic this process
The fact that a compound is being studied in trials does not make a vial purchased online safe, legal, or what it claims to be
FDA approves first generic GLP-1 indicated for weight loss
